DISRUPTION OF DOMINANT B-CELL/PLASMA CELL CLONES IN RHEUMATOID ARTHRITIS SYNOVIUM BY RITUXIMAB CORRELATES WITH TREATMENT RESPONSE

被引：0
|
作者：
Doorenspleet, M. E. [1 ]
Klarenbeek, P. L. [1 ,2 ]
Boumans, M. J. [1 ]
Thurlings, R. M. [1 ]
Esveldt, R. E. [1 ]
van Schaik, B. D.
van Kampen, A. H.
Gerlag, D. M. [1 ]
Baas, F. [3 ]
Tak, P. P. [1 ]
Plenge, R. M. [2 ]
de Vries, N. [1 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
[3] Univ Amsterdam, Acad Med Ctr, Genome Anal Lab, NL-1105 AZ Amsterdam, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.2467
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：313 / 313
页数：1
相关论文
共 50 条
  • [21] B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
    Tuscano, Joseph M.
    Sands, Jacob
    [J]. BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 225 - 232
  • [22] Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response
    Breedveld, Ferdinand
    Agarwal, Sunil
    Yin, Ming
    Ren, Song
    Li, Nicole F.
    Shaw, Tim M.
    Davies, Brian E.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (09): : 1119 - 1128
  • [23] B-cell: a logical target for treatment of rheumatoid arthritis
    Youinou, P.
    Jamin, C.
    Saraux, A.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (02) : 318 - 328
  • [24] THE B-CELL SYSTEM IN THE RHEUMATOID INFLAMMATION - NEW INSIGHTS INTO THE PATHOGENESIS OF RHEUMATOID-ARTHRITIS USING SYNOVIAL B-CELL HYBRIDOMA CLONES
    NATVIG, JB
    RANDEN, I
    THOMPSON, K
    FORRE, O
    MUNTHE, E
    [J]. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1989, 11 (03): : 301 - 313
  • [25] Non-response to rituximab therapy in rheumatoid arthritis is associated with incomplete disruption of the B cell receptor repertoire
    Pollastro, Sabrina
    Klarenbeek, Paul L.
    Doorenspleet, Marieke E.
    van Schaik, Barbera D. C.
    Esveldt, Rebecca E. E.
    Thurlings, Rogier M.
    Boumans, Maria J. H.
    Gerlag, Danielle M.
    Tak, Paul P.
    Vos, Koen
    Baas, Frank
    van Kampen, Antoine H. C.
    de Vries, Niek
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (10) : 1339 - 1345
  • [26] Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis
    Hainsworth, JD
    [J]. ARTHRITIS RESEARCH & THERAPY, 2003, 5 (Suppl 4) : S12 - S16
  • [27] Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis
    John D Hainsworth
    [J]. Arthritis Res Ther, 5
  • [28] Response to rituximab therapy in RA correlates with variable B cell expression in peripheral blood and synovium
    Dass, S.
    Coulthard, L.
    Rawstron, A. C.
    English, A.
    Vital, E. M.
    Reece, R.
    Bingham, S. J.
    McDermott, M.
    Emery, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 186 - 186
  • [29] B Cell Repopulation and Rheumatoid Factor Predict Duration of Response to Rituximab in Rheumatoid Arthritis
    Vital, Edward M.
    Das, Sudipto
    Dass, Shouvik
    Buch, Maya H.
    Ponchel, Frederique
    Rawstron, Andrew
    Emery, Paul
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S642 - S642
  • [30] B-Cell Therapies for Rheumatoid Arthritis
    Scher, Jose U.
    [J]. BULLETIN OF THE HOSPITAL FOR JOINT DISEASES, 2012, 70 (03): : 200 - 203
12345